Apotex Inc, Pharmaceutical Import Profile — Canada (DGFT 2022–2026)

Name: Apotex Inc, Pharmaceutical Import Records from India — 14 Products, $40.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Apotex Inc, — Pharmaceutical Importer Profile (2026) | 14 Products, $40.9M Trade | TransData Nexus

Apotex Inc,

Pharmaceutical Importer · Canada · Cardiovascular Focus · $40.9M Total Trade · DGFT Verified

Apotex Inc, is a pharmaceutical importer based in Canada with a total trade value of $40.9M across 14 products in 7 therapeutic categories. Based on 900 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Apotex Inc, sources from 1 verified Indian supplier, with Apotex Research Private Limited accounting for 100.0% of imports.

Apotex Inc, — Import Portfolio & Supplier Network

Apotex Inc, import network — 14 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Apotex Inc,?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Apotex Research Private Limited	$36.2M	1,027	100.0%

Apotex Inc, sources from 1 verified Indian supplier across 749 distinct formulations. The sourcing is highly concentrated — Apotex Research Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Apotex Inc, Import?

Formulation	Value	Ships
Apo-apixaban fct 5MG 500 btl	$500.0K	10
Apo-desvenlafaxine succ erfct100mg	$400.0K	8
Apo-apixaban fct 5MG 180 btl	$400.0K	8
Apo-atorvastatin fct 20MG 500 btl	$385.0K	8
Apo-desvenlafaxine succ er fct50mg	$367.5K	8
Apo-atorvastatin fct 20MG 100 btl	$350.0K	7
Apo-acetaminophen 500MG TAB 100 u/d	$350.0K	7
Apo-desvenlafaxine succ erfct100mg	$300.0K	6
Apixaban fct 5MG 180 btl siv	$300.0K	6
Apo-atorvastatin fct 10MG 500 btl	$300.0K	6
Apo-apixaban fct 5MG 500 btl 68198 /	$300.0K	6
Apo-rosuvastatin fct 20MG 500 btl	$250.0K	5
Apo-perindopril TAB 4MG 30 bls	$236.2K	6
Apo-escitalopram fct 10MG 100 btl	$201.3K	5
Apo-rosuvastatin fct 10MG 500 btl	$200.0K	4

Import Portfolio — Top 14 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Apixaban	Cardiovascular	$12.0M	240	3.4%	4
2	Fluticasone	Respiratory	$7.9M	182	3.9%	4
3	Atorvastatin	Cardiovascular	$4.0M	81	0.4%	18
4	Amino	Nutritional Supplements	$2.7M	57	0.8%	16
5	Acetaminophen	Analgesics & Antipyretics	$2.5M	54	1.1%	11
6	Ramipril	Cardiovascular	$1.8M	45	2.0%	10
7	Rivaroxaban	Cardiovascular	$1.8M	44	2.4%	4
8	Naproxen	Analgesics & Antipyretics	$1.7M	34	1.2%	19
9	Celecoxib	Analgesics & Antipyretics	$1.5M	36	1.1%	12
10	Escitalopram	CNS & Psychiatric	$1.3M	42	0.7%	19
11	Azathioprine	Immunosuppressants	$1.1M	23	1.8%	4
12	Paclitaxel	Oncology	$1.1M	21	0.7%	7
13	Protein	Nutritional Supplements	$1.1M	21	4.0%	3
14	Pravastatin	Cardiovascular	$409.3K	20	1.3%	13

Apotex Inc, imports 14 pharmaceutical products across 7 categories into Canada totaling $40.9M.

Apotex Inc, — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Apotex Inc. is a Canadian-based global pharmaceutical company, established in 1974 by Barry Sherman. Headquartered in Toronto, Ontario, Apotex has grown to become Canada's largest producer of generic medications, employing approximately 8,000 individuals as of 2023. The company offers a diverse portfolio that includes over 550 generic, biosimilar, and innovative medicines, along with more than 225 natural health products. Apotex's products are distributed across more than 115 countries, reflecting its significant presence in the global pharmaceutical market.

In Canada, Apotex plays a pivotal role in the pharmaceutical distribution network. As the largest Canadian-owned pharmaceutical company, it is a key supplier of generic drugs, contributing to the accessibility and affordability of medications for Canadian patients. The company's extensive manufacturing and distribution capabilities enable it to meet the diverse healthcare needs of the Canadian population.

2Distribution Network

Apotex operates an integrated network of research, manufacturing, and distribution facilities across North America. In Canada, the company has a significant presence with facilities in Montreal, Richmond Hill, Toronto, Etobicoke, Mississauga, Brantford, Windsor, Winnipeg, London, Calgary, and Vancouver. This extensive infrastructure supports the company's logistics capabilities, ensuring efficient production and distribution of pharmaceutical products. Apotex's distribution network is designed to meet the rigorous demands of modern healthcare systems, including the complex needs of the U.S. market, indicating a robust and adaptable logistics framework.

3Industry Role

Apotex Inc. serves as a primary wholesaler and distributor within Canada's pharmaceutical supply chain. By manufacturing and supplying a wide range of generic medications, the company ensures that Canadian patients have access to affordable and effective treatments. Apotex's role is crucial in maintaining the stability and reliability of the pharmaceutical supply chain, particularly in the generic drug sector.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Apotex Inc,

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Apotex's sourcing strategy exhibits a high degree of concentration, with a significant portion of its pharmaceutical formulations imported from a single supplier, Apotex Research Private Limited. This single-source dependency could pose risks related to supply chain disruptions, such as production delays or quality control issues. However, the consistent volume of shipments—1,027 in total—suggests a stable and long-term relationship between Apotex and its supplier. The high concentration in sourcing may also reflect strategic decisions aimed at ensuring quality control and cost efficiency. Nonetheless, over-reliance on a single supplier could limit Apotex's flexibility in responding to market changes or diversifying its product offerings.

2Supply Chain Resilience

Apotex's supply chain resilience is closely tied to its relationship with Apotex Research Private Limited. The lack of backup suppliers for its imported formulations indicates potential vulnerabilities in the event of supply disruptions. Additionally, the limited diversity in formulations imported from India may expose Apotex to risks associated with regulatory changes or quality issues affecting its sole supplier. To enhance supply chain resilience, Apotex could consider diversifying its supplier base and increasing the variety of formulations sourced from different regions.

Importing Pharmaceuticals into Canada — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Canada

1Regulatory Authority & Framework

In Canada, the primary regulatory authority overseeing pharmaceutical imports is Health Canada. The Food and Drugs Act and its associated regulations govern the importation, sale, and distribution of pharmaceutical products. For foreign manufacturers, including those from India, obtaining a Drug Establishment License (DEL) from Health Canada is mandatory to import and distribute drugs in Canada. The process involves demonstrating compliance with Good Manufacturing Practices (GMP) and providing evidence of product safety, efficacy, and quality.

2Import Licensing & GMP

Indian pharmaceutical exporters aiming to supply Apotex must ensure their products meet Health Canada's GMP requirements. Recognized certifications include EU GMP, WHO GMP, and PIC/S. Additionally, obtaining a DEL is essential for legal importation and distribution in Canada. This process requires comprehensive documentation and adherence to Canadian regulatory standards.

3Quality & Labeling

Imported pharmaceutical products must undergo batch testing to confirm their quality and compliance with Canadian standards. Stability studies are required to ensure product efficacy throughout its shelf life. Labeling must be in both English and French, as per Canadian regulations, and should include detailed information on dosage, administration, and potential side effects. Serialization mandates may apply to enhance traceability and prevent counterfeit products.

Apotex Inc, — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Apotex's focus on importing formulations in the cardiovascular, respiratory, and analgesics & antipyretics categories aligns with prevalent health concerns in Canada. The high import values in these therapeutic areas indicate strong market demand and Apotex's strategic positioning to meet these needs. By concentrating on these categories, Apotex can leverage its supply chain efficiencies and expertise to maintain a competitive edge.

2Sourcing Profile

Apotex's sourcing strategy emphasizes high-quality generic formulations, primarily imported from India. This approach allows the company to offer cost-effective alternatives to brand-name drugs, thereby expanding access to essential medications. India's robust pharmaceutical manufacturing sector, with its adherence to international GMP standards, makes it a reliable source for Apotex's procurement needs.

3Market Positioning

Apotex serves a broad segment of the Canadian pharmaceutical market, including retail pharmacies, hospitals, government tenders, and wholesale distribution. Its extensive product portfolio and distribution capabilities enable it to meet the diverse needs of healthcare providers and patients across the country. By offering a wide range of generic medications, Apotex contributes to the sustainability and affordability of Canada's healthcare system.

Seller's Guide — How to Become a Supplier to Apotex Inc,

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter Apotex's supply chain. By offering high-quality, GMP-compliant formulations in therapeutic areas where Apotex seeks to expand or diversify, Indian exporters can position themselves as valuable partners. Establishing relationships with Apotex may require navigating complex regulatory requirements and demonstrating consistent product quality.

2Requirements & Qualifications

Indian exporters aiming to supply Apotex must obtain a Drug Establishment License from Health Canada and ensure their products comply with Canadian GMP standards. Recognized certifications include EU GMP, WHO GMP, and PIC/S. Additionally, products must meet Health Canada's labeling and packaging requirements, including bilingual labeling and serialization mandates.

3How to Approach

To build a relationship with Apotex, Indian exporters should first ensure compliance with Canadian regulatory standards and obtain the necessary certifications. Engaging in direct communication with Apotex's procurement and regulatory affairs departments is crucial. Participating in industry trade shows and forums can also provide opportunities to showcase products and establish connections. Understanding Apotex's strategic priorities and aligning product offerings accordingly will enhance the potential for collaboration.

Frequently Asked Questions — Apotex Inc,

What products does Apotex Inc, import from India?

Apotex Inc, imports 14 pharmaceutical products across 7 categories. Top imports: Apixaban ($12.0M), Fluticasone ($7.9M), Atorvastatin ($4.0M), Amino ($2.7M), Acetaminophen ($2.5M).

Who supplies pharmaceuticals to Apotex Inc, from India?

Apotex Inc, sources from 1 verified Indian suppliers. The primary supplier is Apotex Research Private Limited (100.0% of imports, $36.2M).

What is Apotex Inc,'s total pharmaceutical import value?

Apotex Inc,'s total pharmaceutical import value from India is $40.9M, based on 900 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Apotex Inc, focus on?

Apotex Inc, imports across 7 categories. The largest: Cardiovascular (49.1%), Respiratory (19.2%), Analgesics & Antipyretics (13.9%).

Get Full Apotex Inc, Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 3 company name variants from customs records. For current shipment-level data, contact TransData Nexus.